CAZ Investments raises $29M fund | Wall Street Beat Wall Street Beat

CAZ Investments raised a nearly $29 million funding round it plans to use to back medical companies that already have products on the market.

The Houston-based asset management firm reeled in $28.7 million from 61 unnamed investors, according to a regulatory filing.

CAZ Investments chairman Christopher Zook said the firm plans to use the cash to invest in commercialized companies.

Sign up to get our free newsletters delivered straight to your inbox

"For this fund, we don’t have as long a lag time. Typically, when you make a venture capital investment it’s a concept and you have to wait for it to go through the entire process. We’re investing only in products in the marketplace already generating revenue," Zook told the International Venture Capital Post.

 Will new SEC rules kill angel investing?
New rules adopted by the SEC could threaten angel investing in startups, according to the Angel Capital Assn., including a ban on self-accreditation by potential investors.
Read more

 VC-backed IPOs up during Q2
Venture capital-backed initial public offerings were up during the 2nd quarter, with 22 firms with VC backers went public for a total valuation of roughly $9.6 billion.
Read more

 Nikon eyes the medical device market
Nikon could look to bolster flagging compact camera sales by following rivals Canon and Sony into the medical device business.
Read more

 Mindray closes $105M Zonare buy
Mindray (NYSE:MR) said it closed a $105 million buyout of Zonare Medical Systems and its ultrasound technology.
Read more

 Analysts’ ups and downs

  • Allscripts (NSDQ:MDRX): ISI Group downgrades from “buy” to “neutral” rating, raises price target to $16.50 from $15.50.
  • C.R. Bard (NYSE:BCR): Atlantic Securities initiates coverage with “neutral” rating, $115 price target; Morgan Stanley reiterates "underweight" rating.
  • Cerner (NSDQ:CERN): First Analysis downgrades from “overweight” to “equal weight” rating.
  • Danaher (NYSE:DHR): Morgan Stanley reiterates "overweight" rating, raises price target from $68 to $72.
  • Fresenius (NYSE:FMS): Jefferies Group upgrades from “hold” to “buy” rating.
  • Hologic (NSDQ:HOLX): Piper Jaffray downgrades to "neutral" from "overweight" rating, $21 price target.
  • Intuitive Surgical (NSDQ:ISRG): Leerink Swann maintains “market perform” rating.
  • Johnson & Johnson (NYSE:JNJ): Deutsche Bank downgrades to "neutral" from "buy" rating, $93 price target; Jefferies raises price target to $95, ups estimates, sets "hold" rating; Leerink Swann reiterates “outperform” rating, raises price target to $98 from $94.
  • Mallinckrodt plc (NYSE: MNK): UBS AG initiates coverage with “neutral” rating, $43.00 price target.
  • NuVasive Inc. (NSDQ:NUVA): BMO Capital Markets downgrades from “market perform” to “underperform” rating, raises price target from $18 to $22
  • Optos plc (LON:OPTS): Canaccord Genuity reaffirms "buy" rating, £2.48 ($3.75) price target
  • ResMed (NYSE:RMD): Needham & Co. initiates coverage with “hold” rating.
  • Stryker (NYSE:SYK): TheStreet reaffirms "buy" rating.
  • Sunshine Heart (ASX:SHC): Oppenheimer initiates coverage with "outperform" rating, $11 price target.
  • Volcano (NSDQ:VOLC): Oppenheimer initiates coverage with "outperform" rating, $24 price target.

RSS From Medical Design & Outsourcing

  • GlobTek presents its latest level VI AC/DC adapter and connverter
    T-43086-WWVV-X.X-Q Model is an addition to GlobTek’s Level VI compliant GT-43086 family and represents GlobTek’s 6 Watt wall plug-in series of AC/DC adapters (power supplies and chargers) with International Interchangeable blades. GlobTek’s changeable input blade system with individual field replaceable input plugs, including: North America and Japan NEMA 1-15P, Australian, UK BS 1363, European CEE […]
  • Sanmina’s familiarity with FDA gets skin treatment product to market fast
    The medical market for cosmetic devices is booming. However, quickly launching new products to meet demand is becoming more challenging because device manufactures face increased regulatory scrutiny. To help meet regulatory requirements, aesthetic and other medical-device OEMs are partnering with electronics manufacturing services (EMS) companies that also offer expertise with the FDA filings necessary to […]
  • Fluid connectors and quick disconnects for IVD equipment from CPC
    Colder Products Company (CPC) offers thousands of tubing connectors, quick disconnects and fittings for smart fluid handling in IVD and analytical equipment. Non-spill connectors speed testing throughput by eliminating drips, preventing air inclusion and increasing operator safety. Panel mount connectors can be added to existing equipment or bottle caps to provide secure, leak-free connections. Puncture […]
  • 310 Watt desktop medical power supply meets efficiency level VI requirements
    Power Partners releases a new 310 Watt medical grade desktop power supply from their PEAMD Series of AC and DC adapters. The 310 Watt unit is packed for ideal performance inside a compact case measuring 7.8 x 4 x 2 in. with a weight of only 3 lbs. The PEAMD310 Series is approved to the latest […]
  • Saelig introduces Multiple Instrument System MIS4 universal test system
    Saelig Company has introduced the ABI Electronics’ Multiple Instrument Station MIS4, an all-in-one testing tool that provides all commonly required test instruments in one compact programmable hardware module, mounted in a compact case or installed in a PC-drive bay. Controlled by ABI’s sophisticated SYSTEM 8 Ultimate PC software with a simple yet programmable operator interface, […]
  • AssurX announces document management software update for small to mid-size companies in FDA regulated industries
    AssurX, an enterprise quality management, risk and regulatory compliance solution provider, announces the release of the latest update to their AssurX document management software. The document management solution provides a cost-effective solution for small to medium sized companies faced with streamlined operations and is fully compliant for FDA regulated industries. Ideal solution for small to […]
  • Saelig presents new Amplicon Impact-R 1100F series computer
    Saelig Company announces the Amplicon Impact-R 1100F series, a fanless system powered by the Intel ATOM D2550 processor. Configured with a high performance 2.5 in. MLC Solid State Drive (SSD), the Impact-R 1100F series is a silent controller system. With options for multiple serial communication ports, the Impact-R 1100F can offer up seven DB9 connections […]
  • Gerresheimer to acquire Centor
    Gerresheimer AG, a partner to the global pharmacy and healthcare industry, will further extend its pharmaceutical packaging business with the acquisition of Centor. Gerresheimer has reached an agreement with Nemera Development S.A. to acquire 100% of the share capital of Centor US Holding. “Centor is the highly profitable market leader for plastic vials and closures in […]
  • Methods Machine Tools presents the new Nakamura-Tome NTRX-300
    Methods Machine Tools, a developer of precision machine tools and automation, has introduced the new Nakamura-Tome NTRX-300, a multitasking turning center featuring complete parts machining in one operation, with a built-in load and unload automation system and advanced operator recognition management software. The NTRX-300 features true opposing twin spindles: an 8 in. A2-6 25 HP or […]
  • MSC Apex Diamond Python and Smart Midsurface speeds modeling to validation
    MSC Software announced a new release of MSC Apex, the company’s award-winning next generation Computer Aided Engineering (CAE) platform. The MSC Apex Diamond Python release introduces: · The fourth release of MSC Apex Modeler is a CAE Specific direct modeling and meshing solution that streamlines CAD clean-up, simplification and meshing workflow. New in this release is […]
  • Quality Metrics: FDA’s plan for a key set of measurements to help ensure manufacturers are producing quality medications
    Editor’s Note: This article is written by Ashley Boam and Mary Malarkey from the “FDA Voice” blog. Boam is an FDA’s acting Director of the Office of Policy for Pharmaceutical Quality, the Office of Pharmaceutical Quality and the Center for Drug Evaluation and Research. Malarkey is an FDA’s Director if the Office of Compliance and Biologics Quality […]

Leave a Reply